Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation—The POWER Survey

Table 3

Summary of suspected adverse drug reactions (SADRs) and in-study deaths recorded during POWER.

Adverse event	Number of events; (No. of patients)
SADRs	374 (298)
SADRs leading to study discontinuation	255 (205)
Serious SADRs	14 (11)
Severe SADRs	36 (29)
Deaths	5 (5)